ClassID:

109048

C12N15/113 - page 26 - CPC Classification

Classification description:

Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; DNA or RNA fragments; Modified forms thereof Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Recent Application in this class:
#7501
20180044694
2018-02-15

DOWN-REGULATION OF A HOMEODOMAIN-LEUCINE ZIPPER I-CLASS HOMEOBOX GENE FOR IMPROVED PLANT PERFORMANCE

#7502
20180044681
2018-02-15

Methods of treating cancer harboring hemizygous loss of TP53

#7503
20180044677
2018-02-15

Regulation of translation of expressed genes

#7504
20180044676
2018-02-15

Compositions and methods for modulating TTR expression

#7505
20180044675
2018-02-15

Antisense nucleic acids

#7506
20180044674
2018-02-15

Zn-DPA complex compounds and siRNA delivery systems containing the same

#7507
20180044673
2018-02-15

METHODS FOR MODULATING MECP2 EXPRESSION

#7508
20180044672
2018-02-15

Pericyte Long Non-Coding RNAs

#7509
20180044671
2018-02-15

DOUBLE-STRANDED OLIGONUCLEOTIDE MOLECULES TO P53 AND METHODS OF USE THEREOF

#7510
20180044424
2018-02-15

Car-expressing cells against multiple tumor antigens and uses thereof

#7511
20180043031
2018-02-15

Amphipathic peptide

#7512
20180043009
2018-02-15

Lipids and compositions for the delivery of therapeutics

#7513
20180042991
2018-02-15

RECOMBINANT GLUT1 ADENO-ASSOCIATED VIRAL VECTOR CONSTRUCTS AND RELATED METHODS FOR RESTORING GLUT1 EXPRESSION

#7514
20180042849
2018-02-15

Cochleates and methods of using the same to enhance tissue penetration of pharmacologically active agent

#7515
20180038868
2018-02-08

Beta-catenin inhibitors in cancer immunotherapy

#7516
20180037956
2018-02-08

SIGNATURE OF HEALTH

#7517
20180037907
2018-02-08

Glycaspis Brimblecombei Control Agents

#7518
20180037895
2018-02-08

COMPOSITIONS AND METHODS FOR EFFICACIOUS AND SAFE DELIVERY OF SIRNA USING SPECIFIC CHITOSAN-BASED NANOCOMPLEXES

#7519
20180037893
2018-02-08

Low molecular weight cyclic amine containing cationic lipids for oligonucleotide delivery

#7520
20180037891
2018-02-08

Treatment of NANOG related diseases by inhibition of natural antisense transcript to NANOG

#7521
20180037890
2018-02-08

Oligonucleotide compositions and uses thereof

#7522
20180037889
2018-02-08

ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHODS OF TREATING DYSTROPHIES

#7523
20180037888
2018-02-08

Short interfering RNA for treating cancer

#7524
20180037887
2018-02-08

GENE EXPRESSION REGULATION SYSTEM OF SYNECHOCOCCUS ELONGATUS PCC 7942 AND APPLICATION THEREOF

#7525
20180037886
2018-02-08

Compositions and methods for inhibiting expression of the ALAS1 gene

#7526
20180037617
2018-02-08

Methods and compositions for treating and/or preventing a disease or disorder associated with abnormal level and/or activity of the IFP35 family of proteins

#7527
20180031571
2018-02-01

Method for diagnosing a molecular phenotype of a patient suffering from an illness accompanied by chronic inflammation

#7528
20180030472
2018-02-01

COMPOSITIONS AND METHODS FOR INSECTICIDAL CONTROL OF STINKBUGS

#7529
20180030454
2018-02-01

RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)

#7530
20180030452
2018-02-01

TARGETING OLIGONUCLEOTIDES AND USES THEREOF TO MODULATE GENE EXPRESSION

#7531
20180030450
2018-02-01

Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical field

#7532
20180030448
2018-02-01

Pharmaceutical Composition Consisting Of RNA Having Alkali Metal As Counter Ion And Formulated With Dications

#7533
20180030445
2018-02-01

Compositions and methods using capsids resistant to hydrolases

#7534
20180030444
2018-02-01

Multimeric oligonucleotide compounds having non-nucleotide based cleavable linkers

#7535
20180030443
2018-02-01

NON-IONIC, LOW OSMOLAR CONTRAST AGENTS FOR DELIVERY OF ANTISENSE OLIGONUCLEOTIDES AND TREATMENT OF DISEASE

#7536
20180030442
2018-02-01

MicroRNA therapy for pancreatic cancer

#7537
20180030441
2018-02-01

siRNA compounds comprising terminal substitutions

#7538
20180030440
2018-02-01

Pharmaceutical composition for treating cancer comprising microrna as active ingredient

#7539
20180030439
2018-02-01

Oligonucleotide therapy for leber congenital amaurosis

#7540
20180030438
2018-02-01

MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES

#7541
20180030437
2018-02-01

Acyl-amino-LNA and/or hydrocarbyl-amino-LNA oligonucleotides

#7542
20180028713
2018-02-01

Methods and compositions for wound healing

#7543
20180028687
2018-02-01

Extracellular vesicles for agent delivery

#7544
20180028557
2018-02-01

Hybrid oligonucleotides and uses thereof

#7545
20180028554
2018-02-01

Oligomers Having Bicyclic Scaffold Moeities

#7546
20180028458
2018-02-01

COATED CHITOSAN-BASED POLYPLEX FOR DELIVERY OF NUCLEIC ACIDS

#7547
20180028456
2018-02-01

Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells

#7548
20180028449
2018-02-01

Technology for the Preparation of Microparticles

#7549
20180023142
2018-01-25

MICRORNAS IN NEURODEGENERATIVE DISORDERS

#7550
20180023094
2018-01-25

Recombinant AAV variants and uses thereof

#7551
20180023086
2018-01-25

Compositions and methods for inhibiting gene expression of factor XII

#7552
20180023084
2018-01-25

Disulfide-containing alkyne linking agents

#7553
20180023083
2018-01-25

Double strand RNA as molecular biopesticides for RNA interference through feeding in the hemipteran invasive insect pest, brown marmorated stink bug

#7554
20180023082
2018-01-25

Variant RNAi

#7555
20180023081
2018-01-25

LNA OLIGONUCLEOTIDES WITH ALTERNATING FLANKS

#7556
20180023080
2018-01-25

Long Non-Coding RNA For The Treatment Of Endothelial Dysfunction

#7557
20180023079
2018-01-25

Circular RNA For The Diagnosis Of Cardiovascular And Inflammatory Diseases

#7558
20180023078
2018-01-25

Oligonucleotide sequences targeting transcription factor TSC22D4 for the treatment of insulin resistance

#7559
20180023077
2018-01-25

Compositions for modulating expression of C9ORF72 antisense transcript

#7560
20180023076
2018-01-25

DOUBLE STRAND RNA DELIVERY SYSTEM FOR PLANT-SAP-FEEDING INSECTS

#7561
20180023075
2018-01-25

Compositions and methods for enhancing homologous recombination

#7562
20180022878
2018-01-25

Facile assembly of soft nanoarchitectures and co-loading of hydrophilic and hydrophobic molecules via flash nanoprecipitation

#7563
20180022831
2018-01-25

Nanoparticle-protein complex for intracellular protein delivery

#7564
20180022792
2018-01-25

Biological Materials and Uses Thereof

#7565
20180022779
2018-01-25

Compositions and methods for regulating arterial tone

#7566
20180021457
2018-01-25

Endonuclease targeting blood coagulation factor VIII gene and composition for treating hemophilia comprising same

#7567
20180021447
2018-01-25

Lipid Nanoparticle Compositions and Methods of Making and Methods of Using the Same

#7568
20180021441
2018-01-25

Hyperbranched polymers and polyplexes and DNA or RNA delivery systems including the same

#7569
20180021413
2018-01-25

Materials and methods for treatment of hemoglobinopathies

#7570
20180017563
2018-01-18

Use of isocitrate dehydrogenase 1 as a diagnostic and prognostic biomarker and therapeutic target for lung cancers

#7571
20180016585
2018-01-18

Method for improving heterologous synthesis of into polyketides and use of same

#7572
20180016580
2018-01-18

Morpholino oligonucleotide manufacturing method

#7573
20180016579
2018-01-18

Methods for the treatment of Leber congenital amaurosis

#7574
20180016578
2018-01-18

Methods and agents to increase therapeutic dystrophin expression in muscle

#7575
20180016577
2018-01-18

Treatment of facioscapulohumeral dystrophy

#7576
20180016576
2018-01-18

Novel Therapeutic Agent for Septicemia, and a Method for Screening for Same

#7577
20180016575
2018-01-18

LNA Gapmer Oligonucleotides Comprising Chiral Phosphorothioate Linkages

#7578
20180016574
2018-01-18

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

#7579
20180016294
2018-01-18

Oligonucleotide compositions and methods of making the same

#7580
20180016293
2018-01-18

Oligonucleotide compositions and methods of making the same

#7581
20180010195
2018-01-11

Compositions and methods for monitoring, diagnosis, prognosis, detection, and treatment of cancer

#7582
20180010151
2018-01-11

CRISPR-CAS system for a yeast host cell

#7583
20180010131
2018-01-11

Treatment of erythropoietin (EPO) related diseases by inhibition of natural antisense transcript to EPO

#7584
20180010130
2018-01-11

Double-stranded ribonucleic acid as control against insects

#7585
20180010129
2018-01-11

Compositions and methods to promote erythropoiesis

#7586
20180010128
2018-01-11

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#7587
20180010127
2018-01-11

METHOD OF ENHANCING MIR-185 EXPRESSION TO REDUCE LOW DENSITY LIPOPROTEIN/CHOLESTEROL ACCUMULATION IN A CELL

#7588
20180010126
2018-01-11

ANTISENSE COMPOUNDS AND USES THEREOF

#7589
20180010125
2018-01-11

Double-stranded oligonucleotide molecules to DDIT4 and methods of use thereof

#7590
20180009864
2018-01-11

Synthetic promoters for high throughput screening and gene modulation

#7591
20180009837
2018-01-11

Compounds and methods for the modulation of proteins

#7592
20180002716
2018-01-04

Compositions and methods thereof for down-regulation of genes following oral delivery of an RNAi molecule bioencapsulated within plant cells

#7593
20180002713
2018-01-04

Recombinant DNA constructs and methods for controlling gene expression

#7594
20180002703
2018-01-04

Composition for reducing cellular senescence level including activity inhibitor inhibiting DCUN1D3 activity or expression inhibitor inhibiting expression of DCUN1D3-encoding gene and use thereof

#7595
20180002697
2018-01-04

Antisense oligonucleotides for inducing exon skipping and methods of use thereof

#7596
20180002696
2018-01-04

Treatment of sodium channel, voltage-gated, alpha subunit (SCNA) related diseases by inhibition of natural antisense transcript to SCNA

#7597
20180002695
2018-01-04

COMPOUNDS AND METHODS FOR IMPROVED CELLULAR UPTAKE OF ANTISENSE COMPOUNDS

#7598
20180002694
2018-01-04

Reducing intron retention

#7599
20180002693
2018-01-04

COMPOSITIONS AND METHODS

#7600
20180002692
2018-01-04

Sequence Specific and Organism Specific Antimicrobials and Related Materials and Methods

#7601
20180002691
2018-01-04

Compositions and methods for controlling

#7602
20180002690
2018-01-04

Plant regulatory elements and uses thereof

#7603
20180002689
2018-01-04

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

#7604
20180002682
2018-01-04

Heterodimeric Cas9 and methods of use thereof

#7605
20180002413
2018-01-04

Inflammatory disease diagnosis and methods of treatment using down-regulators of lipopolysaccharide-responsive beige-like anchor

#7606
20180001070
2018-01-04

MICRONEEDLE ARRAYS FOR ACTIVE AGENT DELIVERY

#7607
20180000735
2018-01-04

Methods and devices for preparation of lipid nanoparticles

#7608
20170369946
2017-12-28

Blood biomarkers for respiratory infections

#7609
20170369921
2017-12-28

Analysis of nucleic acids associated with single cells using nucleic acid barcodes

#7610
20170369884
2017-12-28

MicroRNAs Sensitize Cancers to Therapy

#7611
20170369882
2017-12-28

FULLY STABILIZED ASYMMETRIC SIRNA

#7612
20170369881
2017-12-28

RNA targeting in alpha-synucleinopathies

#7613
20170369880
2017-12-28

Compositions comprising alternating 2′-modified nucleosides for use in gene modulation

#7614
20170369879
2017-12-28

Methods for treatment of alport syndrome

#7615
20170369878
2017-12-28

MICRORNA COMBINATIONS FOR ANTI-CANCER THERAPEUTICS

#7616
20170369877
2017-12-28

Reduction of off-target RNA interference toxicity

#7617
20170369876
2017-12-28

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

#7618
20170369875
2017-12-28

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

#7619
20170369874
2017-12-28

RAAV-BASED COMPOSITIONS AND METHODS FOR TREATING ALPHA-1 ANTI-TRYPSIN DEFICIENCIES

#7620
20170369873
2017-12-28

PARENTAL RNAI SUPPRESSION OF CHROMATIN REMODELING GENES TO CONTROL COLEOPTERAN PESTS

#7621
20170369872
2017-12-28

REVERSIR TM COMPOUNDS

#7622
20170369866
2017-12-28

COMPOSITIONS AND METHODS FOR EFFICIENT GENE EDITING IN E. COLI USING GUIDE RNA/CAS ENDONUCLEASE SYSTEMS IN COMBINATION WITH CIRCULAR POLYNUCLEOTIDE MODIFICATION TEMPLATES

#7623
20170369841
2017-12-28

Method for modifying T cell population

#7624
20170369556
2017-12-28

RECOMBINANT CELLS COMPRISING miRNA MIMICS

#7625
20170368203
2017-12-28

Compositions for enhancing transport of molecules into cells

#7626
20170363643
2017-12-21

Methods for treating spinal muscular atrophy

#7627
20170363613
2017-12-21

Simultaneous detection of cannibalism and senescence as prognostic marker for cancer

#7628
20170362664
2017-12-21

Treatment of angiogenesis disorders

#7629
20170362596
2017-12-21

Methods and means of generating IL-17 associated antitumor effector cells by inhibition of NR2F6 inhibition

#7630
20170362590
2017-12-21

PHARMACEUTICAL COMPOSITIONS COMPRISING MICRORNA

#7631
20170362580
2017-12-21

METHODS AND COMPOSITIONS FOR SELECTIVELY ELIMINATING CELLS OF INTEREST

#7632
20170362311
2017-12-21

METHODS AND COMPOSITIONS FOR REGULATING IRON HOMEOSTASIS BY MODULATION OF BMP-6

#7633
20170362285
2017-12-21

Methods for tuning carotenoid production levels and compositions in and genera

#7634
20170362279
2017-12-21

VLP WITH A FUSION PROTEIN

#7635
20170362173
2017-12-21

ANTI-ARRHYTHMICITY AGENTS

#7636
20170361243
2017-12-21

Luterion and separating and culturing methods for same

#7637
20170360959
2017-12-21

Formulations for targeted release of agents under low pH conditions and methods of use thereof

#7638
20170360842
2017-12-21

PROCESSES FOR PRODUCING STABLE EXOSOME FORMULATIONS

#7639
20170360840
2017-12-21

EXTRACELLULAR VESICLES WITH ENHANCED POTENCY

#7640
20170360821
2017-12-21

Treatment and prevention of thrombosis using an anti-miR

#7641
20170356903
2017-12-14

OLIGONUCLEOTIDE PROBES AND USES THEREOF

#7642
20170356043
2017-12-14

ACTIVITY-DEPENDENT GENE PAIRS AS THERAPEUTIC TARGETS AND METHODS AND DEVICES TO IDENTIFY THE SAME

#7643
20170356011
2017-12-14

Delivery across cell plasma membranes

#7644
20170356010
2017-12-14

Methods and compositions for transducing lymphocytes and regulating the activity thereof

#7645
20170355995
2017-12-14

Treatment of fibroblast growth factor 21 (FGF21) related diseases by inhibition of natural antisense transcript to FGF21

#7646
20170355994
2017-12-14

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

#7647
20170355993
2017-12-14

Modulation of alternative MDM2 splicing

#7648
20170355992
2017-12-14

Factor V/Va-targeting aptamer compositions and methods of using the same

#7649
20170355991
2017-12-14

COMPOSITIONS AND METHODS TO CONTROL INSECT PESTS

#7650
20170355990
2017-12-14

TREATMENT OF SODIUM CHANNEL, VOLTAGE-GATED, ALPHA SUBUNIT (SCNA) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SCNA

#7651
20170355989
2017-12-14

RNAI induced huntingtin gene suppression

#7652
20170355988
2017-12-14

Mitochondrial phosphate carrier targets for treating soft-tissue calcification

#7653
20170355987
2017-12-14

Inhibitors Of Lactate Transporters For Use In The Treatment Of Inflammatory Diseases

#7654
20170355986
2017-12-14

ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION

#7655
20170355752
2017-12-14

COLON DISEASE TARGETS AND USES THEREOF

#7656
20170355727
2017-12-14

Conjugated antisense compounds and their use

#7657
20170354745
2017-12-14

TARGETED DISRUPTION OF A CSF1-DAP12 PATHWAY MEMBER GENE FOR THE TREATMENT OF NEUROPATHIC PAIN

#7658
20170354673
2017-12-14

Oligonucleotide having non-natural nucleotide at 5′-terminal thereof

#7659
20170350897
2017-12-07

METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING DISEASES

#7660
20170349907
2017-12-07

Methods to monitor post-translational gene silencing activity in plant tissues/cell types relevant for pathogen entry, propagation or replication

#7661
20170349904
2017-12-07

Methods and Compositions for Selecting siRNA of Improved Functionality

#7662
20170349902
2017-12-07

Single-stranded nucleic acid molecule for inhibiting TGF-β1 expression

#7663
20170349899
2017-12-07

Fungal chromosome-end knockoff strategy

#7664
20170349898
2017-12-07

IMMUNOMODULATION BY CONTROLLING ELR+ PROINFLAMMATORY CHEMOKINE LEVELS WITH THE LONG NON-CODING RNA UMLILO

#7665
20170349897
2017-12-07

Compositions for modulating C9ORF72 expression

#7666
20170349896
2017-12-07

Poly oligomer compound with biocleavable conjugates

#7667
20170349623
2017-12-07

NUCLEIC ACID COMPLEX, METHOD FOR FORMING NUCLEIC ACID HYBRIDIZATION, PHARMACEUTICAL COMPOSITION, NUCLEIC ACID PROBE, AND COMPLEMENTARY-STRAND NUCLEIC ACID COMPLEX

#7668
20170349543
2017-12-07

Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids

#7669
20170348432
2017-12-07

Modified polycationic polymers

#7670
20170348346
2017-12-07

Combination therapies for inner ear sensory hair cell regeneration/replacement

#7671
20170348245
2017-12-07

Products for the delivery of therapeutic/diagnostic compounds to the heart

#7672
20170348234
2017-12-07

METHOD AND COMPOSITION FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS

#7673
20170342428
2017-11-30

Plant regulatory elements and uses thereof

#7674
20170342418
2017-11-30

USE OF MICRORNA PRECURSORS AS DRUGS FOR INDUCING CD34-POSITIVE ADULT STEM CELL EXPANSION

#7675
20170342417
2017-11-30

Methods of using microRNA-141

#7676
20170342416
2017-11-30

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

#7677
20170342415
2017-11-30

Methods for the prevention and the treatment of extracapillary glomerulonephritis

#7678
20170342414
2017-11-30

ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF LEBER CONGENITAL AMAUROSIS

#7679
20170342413
2017-11-30

Antisense design

#7680
20170342412
2017-11-30

Antisense design

#7681
20170342411
2017-11-30

Methods and pharmaceutical compositions for treating human immunodeficiency virus type 1 (HIV-1) infections

#7682
20170342410
2017-11-30

Structurally designed shRNAs

#7683
20170342108
2017-11-30

Cell penetrating stapled peptide, manufacturing method therefor, and use thereof

#7684
20170340754
2017-11-30

Efficient delivery of therapeutic molecules in vitro and in vivo

#7685
20170340745
2017-11-30

Nucleic acid complexes

#7686
20170340661
2017-11-30

Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof

#7687
20170335347
2017-11-23

Compositions and methods of engineered CRISPR-CAS9 systems using split-nexus CAS9-associated polynucleotides

#7688
20170335346
2017-11-23

Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides

#7689
20170335344
2017-11-23

Methods and compositions for the activation of gamma-delta T-cells

#7690
20170335329
2017-11-23

ANTISENSE OLIGONUCLEOTIDES DIRECTED AGAINST CONNECTIVE TISSUE GROWTH FACTOR AND USES THEREOF

#7691
20170335328
2017-11-23

Preventing and treating inflammatory skin diseases

#7692
20170335326
2017-11-23

Nucleic acid molecules inducing RNA interference, and uses thereof

#7693
20170335324
2017-11-23

METHODS FOR TREATING NEURODEGENERATIVE DISEASES

#7694
20170335323
2017-11-23

Chiral library screen

#7695
20170335322
2017-11-23

Compounds and methods for the modulation of COMP

#7696
20170335321
2017-11-23

MALAT-1, A NON-CODING RNA, IS A TARGET FOR THE REGULATION OF LEARNING AND MEMORY

#7697
20170335320
2017-11-23

Use of a reverse-transcriptase inhibitor in the prevention and treatment of degenerative diseases

#7698
20170335319
2017-11-23

RNA hydrogel

#7699
20170335318
2017-11-23

RNA interference suppression of neurodegenerative diseases and methods of use

#7700
20170335317
2017-11-23

Methods for modulating ATRX-dependent gene repression

#7701
20170335010
2017-11-23

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

#7702
20170334977
2017-11-23

Targeting Apolipoprotein E (APOE) in Neurologic Disease

#7703
20170334852
2017-11-23

Cationic lipid

#7704
20170333565
2017-11-23

TLR9 TARGETED CYTOTOXIC AGENTS

#7705
20170333555
2017-11-23

Methods for treating and/or limiting development of diabetes

#7706
20170333481
2017-11-23

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

#7707
20170333468
2017-11-23

MIR-214 AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER SPECIFIC FOR ULCERATIVE COLITIS AND A MIR-214 INHIBITOR FOR TREATMENT OF SAME

#7708
20170333361
2017-11-23

Nanoparticle

#7709
20170327828
2017-11-16

Treatment of PAR4 related diseases by inhibition of natural antisense transcript to PAR4

#7710
20170327826
2017-11-16

Neutral nucleic acid ligands

#7711
20170327825
2017-11-16

Decoy oligonucleotides for the treatment of diseases

#7712
20170327824
2017-11-16

SELECTIVE ANTISENSE COMPOUNDS AND USES THEREOF

#7713
20170327823
2017-11-16

Selective Reactivation of Genes on the Inactive X Chromosome

#7714
20170327822
2017-11-16

RNA interference mediating small RNA molecules

#7715
20170327820
2017-11-16

Compositions and methods of nucleic acid-targeting nucleic acids

#7716
20170327600
2017-11-16

RNA-PROTEIN COMPLEX, AND RNA AND PROTEIN DELIVERY SYSTEM USING THE SAME

#7717
20170326255
2017-11-16

Sucrose ester based cationic gene vector and preparation method thereof

#7718
20170326253
2017-11-16

PH-sensitive peptides and their nanoparticles for drug delivery

#7719
20170326244
2017-11-16

Biotin complexes for treatment and diagnosis of Alzheimer'S disease

#7720
20170321225
2017-11-09

Methods, systems, and compositions relating to MiRNA-146a

#7721
20170321219
2017-11-09

Oligonucleotide compositions with enhanced efficiency

#7722
20170321215
2017-11-09

Albumin production and cell proliferation

#7723
20170321214
2017-11-09

DEAD GUIDES FOR CRISPR TRANSCRIPTION FACTORS

#7724
20170321213
2017-11-09

Compositions and methods for inhibiting expression of transthyretin

#7725
20170321198
2017-11-09

CRISPR enzymes and systems

#7726
20170320903
2017-11-09

Antisense nucleic acids

#7727
20170318814
2017-11-09

COMPOSITIONS AND METHODS TO CONTROL INSECT PESTS

#7728
20170314037
2017-11-02

Isolated Novel Nucleic Acid and Protein Molecules from Corn and Methods of Using Those Molecules to Generate Transgenic Plants with Enhanced Agronomic Traits

#7729
20170314029
2017-11-02

Oligonucleotide sequence for use in pathway engineering

#7730
20170314026
2017-11-02

Modulation of prekallikrein (PKK) expression

#7731
20170314021
2017-11-02

AGENT FOR TREATING FIBROSIS OF THE INTESTINE

#7732
20170314020
2017-11-02

MicroRNA-200 based approaches for modulating bone formation inhibition and bone regeneration

#7733
20170314019
2017-11-02

Microrna compositions and methods of making and using same

#7734
20170314018
2017-11-02

LncRNA and oncolytic adenovirus, and application thereof

#7735
20170314017
2017-11-02

miRNA transcriptome methods and compositions

#7736
20170314015
2017-11-02

CRISPR/CAS-related methods and compositions for treating sickle cell disease

#7737
20170312372
2017-11-02

Delivery of small interfering RNA and micro RNA through nanogels containing hydrophobic pseudo-peptides

#7738
20170312367
2017-11-02

Branched oligonucleotides

#7739
20170312304
2017-11-02

miRNA FOR TREATING CANCER AND FOR USE WITH ADOPTIVE IMMUNOTHERAPIES

#7740
20170307608
2017-10-26

Methods of treating transthyretin (TTR) mediated amyloidosis

#7741
20170306399
2017-10-26

Methods for characterizing alternatively or aberrantly spliced mRNA isoforms

#7742
20170306330
2017-10-26

Pharmaceutical composition for treatment of cancer comprising RNA oligonucleotide

#7743
20170306329
2017-10-26

METHODS FOR TREATING EYE DISORDERS

#7744
20170306328
2017-10-26

Method for controlling obesity using minimally invasive means

#7745
20170306327
2017-10-26

Hippo and dystrophin complex signaling in cardiomyocyte renewal

#7746
20170306326
2017-10-26

Microrna inhibitor system and methods of use thereof

#7747
20170306325
2017-10-26

Single-stranded nucleic acid molecule for regulating expression of gene having delivering function

#7748
20170306324
2017-10-26

Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides

#7749
20170306323
2017-10-26

Antisense antiviral compounds and methods for treating a filovirus infection

#7750
20170305978
2017-10-26

ACC OX promoter identified by microarray analysis

#7751
20170304465
2017-10-26

Adeno-associated viral vectors for treating myocilin (MYOC) glaucoma

#7752
20170304459
2017-10-26

METHODS AND COMPOSITIONS FOR INHALATION DELIVERY OF CONJUGATED OLIGONUCLEOTIDE

#7753
20170304368
2017-10-26

POLARIZATION OF MACROPHAGES TO A HEALING PHENOTYPE BY CARDIOSPHERE-DERIVED CELLS AND BY THE EXOSOMES SECRETED BY SUCH CELLS

#7754
20170304348
2017-10-26

MiRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathway

#7755
20170304347
2017-10-26

MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

#7756
20170304269
2017-10-26

Method for treating neurodegenerative diseases

#7757
20170298447
2017-10-19

Nucleic acids related to MiR-29B-1-5P and uses thereof

#7758
20170298362
2017-10-19

ANTI-TUMOR THERAPY

#7759
20170298355
2017-10-19

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

#7760
20170298354
2017-10-19

Organic compositions to treat HSF1-related diseases

#7761
20170298353
2017-10-19

Enhancing dermal wound healing by downregulating microRNA-26a

#7762
20170298352
2017-10-19

COMPOSITIONS AND METHODS FOR TREATING HEPATIC FIBROSIS

#7763
20170298351
2017-10-19

Method For Screening Interfering Molecules

#7764
20170298349
2017-10-19

Intergenic RNAS and methods for modulating gene expression and pathogenesis in

#7765
20170298330
2017-10-19

Set of polypeptides exhibiting nuclease activity or nickase activity with dependence on light or in presence of drug or suppressing or activating expression of target gene

#7766
20170298086
2017-10-19

RNA interference agents for p21 gene modulation

#7767
20170296678
2017-10-19

Methods and compositions for transducing lymphocytes and regulated expansion thereof

#7768
20170292129
2017-10-12

TREATMENT OF C9FTD/ALS BY TARGETING RNA EXPANDED REPEAT SEQUENCES

#7769
20170292126
2017-10-12

Neuroprotective molecules and methods of treating neurological disorders and inducing stress granules

#7770
20170292125
2017-10-12

MULTIPLE EXON SKIPPING COMPOSITIONS FOR DMD

#7771
20170290860
2017-10-12

Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy

#7772
20170290338
2017-10-12

Compositions and methods to control insect pests

#7773
20170283830
2017-10-05

Compositions for enhancing targeted gene editing and methods of use thereof

#7774
20170283828
2017-10-05

Methods for genetic control of insect infestations in plants and compositions thereof

#7775
20170283827
2017-10-05

FSH nucleic acid molecules to control insect pests

#7776
20170283801
2017-10-05

Therapeutic compositions

#7777
20170283800
2017-10-05

Downregulating miR-132 for the treatment of lipid related disorders

#7778
20170283799
2017-10-05

Compositions for treating muscular dystrophy

#7779
20170283798
2017-10-05

TTV miRNA sequences as an early marker for the future development of cancer and as a target for cancer treatment and prevention

#7780
20170283795
2017-10-05

PHOSPHATIDYLINOSITOL-3-KINASE NUCLEIC ACIDS AND USES THEREOF

#7781
20170283502
2017-10-05

Compositions and methods for treating and preventing inflammation

#7782
20170283467
2017-10-05

Programmable polypeptide and nucleic acid nanoparticles

#7783
20170281795
2017-10-05

NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF

#7784
20170281628
2017-10-05

Molecular targets for the treatment of wounds, in particular chronic wounds

#7785
20170275629
2017-09-28

Methods and compositions for the treatment of cancer

#7786
20170275628
2017-09-28

Antisense design

#7787
20170275627
2017-09-28

Chimeric single-stranded antisense polynucleotides and double-stranded antisense agent

#7788
20170275626
2017-09-28

Modified double-stranded RNA agents

#7789
20170275625
2017-09-28

Methods Of Inhibiting Tumorigenesis In Colon Adenocarcinoma And Compositions Therefor

#7790
20170275624
2017-09-28

Methods of Inducing Exon Skipping

#7791
20170275623
2017-09-28

Cancer treatment and immune system regulation through FAT10 pathway inhibition

#7792
20170275622
2017-09-28

ALTERATION OF NEURONAL GENE EXPRESSION BY SYNTHETIC piRNAs AND BY ALTERATION OF piRNA FUNCTION

#7793
20170275621
2017-09-28

Chiral control

#7794
20170275620
2017-09-28

MODULATION OF APOLIPOPROTEIN C-III EXPRESSION

#7795
20170275619
2017-09-28

Compositions and methods for treating vascular disorders

#7796
20170275618
2017-09-28

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF MYC BY DOUBLE-STRANDED RNA

#7797
20170275615
2017-09-28

Methods and compositions for treating leber congenital amaurosis

#7798
20170274000
2017-09-28

Triggering RNA interference with RNA-DNA and DNA-RNA nanoparticles

#7799
20170273905
2017-09-28

Lipid membrane structure for intracellular delivery of siRNA

#7800
20170269093
2017-09-21

Methods for identifying and treating invasive/metastatic breast cancers